Sort
82,697 grants matching “vaccine development”
Optimizing the Immunogenicity of MVA-Based AIDS Vaccines
$4,202,132Emory University · U19 · FY2005 · AI
cGMP Manufacture, Fill-Finish, Release, and Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine
$4,199,938Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2021 · AI
Immunologic strategies to prevent congenital cytomegalovirus transmission and disease in rhesus monkeys
$4,199,924Sallie R. Permar · Weill Medical Coll Of Cornell Univ · P01 · FY2024 · AI
DEVELOPMENT OF A NOVEL CELL-BASED, LIVE INFLUENZA VACCINE WITH UNIVERSAL ATTRIBUTES
$4,198,890Flugen Inc · · FY2019 · Department of the Army
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$4,197,323Pamela J Bjorkman · California Institute Of Technology · P01 · FY2024 · AI
Cancer Immunotherapy
$4,195,237James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Harvard University Center for AIDS Research
$4,195,217Bruce D Walker · Harvard University · P30 · FY2012 · AI
Development And Production Of A Multiclade HIV-1 DNA Plasmid Vaccine
$4,188,372Kimberly Wallace · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$4,186,577Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$4,186,577Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$4,186,577Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$4,186,577Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N
$4,181,877Laurence Lemiale · Emergent Product Development Gaithersbur · N01 · FY2016 · AI
Immune Reconstitution
$4,179,106Ronald E. Gress · Basic Sciences · Z01 · FY2007 · CA
SHIV Env-antibody coevolution as a molecular guide to HIV-1 V3 glycan targeted vaccine design
$4,178,808George M Shaw · University Of Pennsylvania · P01 · FY2022 · AI
IGF::OT::IGF NIAID Preclinical Development Support- cGMP Manufacturing of PGT121 and PGDM1400 Antibodies
$4,174,500John Mascola · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI
Targeting mTOR and CD40 Pathways for Adjuvanting HIV Vaccines
$4,170,549Rama Rao Amara · Emory University · P01 · FY2011 · AI
NIA AD/ADRD Health Care Systems Research Collaboratory
$4,168,993Vincent Mor · Brown University · U54 · FY2021 · AG
COVID-19: NIAID Clinical Research Support Services (CRSS)
$4,167,596Bambra Strokes · Ppd Development Lp · N01 · FY2022 · AI
FEND for TB
$4,167,230Jerrold J. Ellner · Rbhs-New Jersey Medical School · U01 · FY2022 · AI
Prevention Research Center: Parenting Among Women Who Are Opioid Users
$4,166,575Leslie Diane Leve · University Of Oregon · P50 · FY2020 · DA
Infectious Diseases Fellowship Program
$4,161,584Christa Zerbe · National Institute Of Allergy And Infectious Diseases · ZIE · FY2024 · AI
ARRA: H1N1 Influenza Disease Modeling and Transmission
$4,154,469Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
UAB Center for AIDS Research
$4,153,930Michael S. Saag · University Of Alabama At Birmingham · P30 · FY2013 · AI
New England Regional Center of Excellence for Biodefense
$4,152,399Harvard University (Medical School) · U54 · FY2003 · AI